Investigating sex differences in rates and correlates of food addiction status in women and men with ptsd

Background: Food addiction (FA) is a dysregulated eating pattern characterized by difficulties in controlling the intake of certain foods. There is an overlap in physical and mental health correlates of FA and post-traumatic stress disorder (PTSD). The purpose of this study was to examine sex differences in the rates of positive FA status in individuals with threshold/subthreshold PTSD, and to examine sex differences in the physical and mental health correlates of FA. Methods: Post-9/11 veterans/service members seeking PTSD treatment were recruited. Participants were diagnosed with PTSD via the administration of a clinical interview. FA status was determined using Modified Yale Food Addiction Scale-2, binary sex and body mass index were assessed with demographics questions. Results: Nearly half (43%) of the sample were women. There were no sex differences in the rates of FA, with an overall FA prevalence of 18%. There were no sex differences in FA symptom count in the whole sample (M = 1.63) or those with FA status (M = 6.21). Individuals with FA reported higher frequency of disordered eating, higher severity of PTSD, and depression symptoms. Conclusions: FA should be assessed in tandem with PTSD symptoms, as its prevalence in that sample is higher than in the general population, and it appears to affect both sexes at similar rates

Immersive technology and medical visualisation: a user's guide

The immersive technologies of Virtual and Augmented Reality offer a new medium for visualisation. Where previous technologies allowed us only two-dimensional representations, constrained by a surface or a screen, these new immersive technologies will soon allow us to experience three dimensional environments that can occupy our entire field of view. This is a technological breakthrough for any field that requires visualisation, and in this chapter I explore the implications for medical visualisation in the near-to-medium future. First, I introduce Virtual Reality and Augmented Reality respectively, and identify the essential characteristics, and current state-of-the-art, for each. I will then survey some prominent applications already in-use within the medical field, and suggest potential use cases that remain under-explored. Finally, I will offer practical advice for those seeking to exploit these new tools

User-Centered Virtual Reality for Promoting Relaxation: An Innovative Approach

[EN] Virtual reality has been used effectively to promote relaxation and reduce stress. It is possible to find two main approaches to achieve such aims across the literature. The first one is focused on genetic environments filled with relaxing "narratives" to induce control over one's own body and physiological response, while the second one engages the user in virtual reality-mediated activities to empower his/her own abilities to regulate emotion. The scope of the present contribution is to extend the discourse on VR use to promote relaxation, by proposing a third approach. This would be based on VR with personalized content, based on user research to identify important life events. As a second step, distinctive features of such events may be rendered with symbols, activities or other virtual environments contents. According to literature, it is possible that such an approach would obtain more sophisticated and long-lasting relaxation in users. The present contribution explores this innovative theoretical proposal and its potential applications within future research and interventionsPizzoli, SFM.; Mazzocco, K.; Triberti, S.; Monzani, D.; Alcañiz Raya, ML.; Pravettoni, G. (2019). User-Centered Virtual Reality for Promoting Relaxation: An Innovative Approach. Frontiers in Psychology. 10:1-8. https://doi.org/10.3389/fpsyg.2019.00479S1810Alcañiz, M., Botella, C., Baños, R. M., Zaragoza, I., & Guixeres, J. (2009). The Intelligent e-Therapy system: a new paradigm for telepsychology and cybertherapy. British Journal of Guidance & Counselling, 37(3), 287-296. doi:10.1080/03069880902957015Alcañiz, M., Botella, C., Rey, B., Baños, R., Lozano, J. A., de la Vega, N. L., … Hospitaler, A. (2007). EMMA: An Adaptive Display for Virtual Therapy. Lecture Notes in Computer Science, 258-265. doi:10.1007/978-3-540-73216-7_29Anderson, A. P., Mayer, M. D., Fellows, A. M., Cowan, D. R., Hegel, M. T., & Buckey, J. C. (2017). Relaxation with Immersive Natural Scenes Presented Using Virtual Reality. Aerospace Medicine and Human Performance, 88(6), 520-526. doi:10.3357/amhp.4747.2017Annemans, L., Redekop, K., & Payne, K. (2013). Current Methodological Issues in the Economic Assessment of Personalized Medicine. Value in Health, 16(6), S20-S26. doi:10.1016/j.jval.2013.06.008Annerstedt, M., Jönsson, P., Wallergård, M., Johansson, G., Karlson, B., Grahn, P., … Währborg, P. (2013). Inducing physiological stress recovery with sounds of nature in a virtual reality forest — Results from a pilot study. Physiology & Behavior, 118, 240-250. doi:10.1016/j.physbeh.2013.05.023Baños, R. M., Botella, C., Alcañiz, M., Liaño, V., Guerrero, B., & Rey, B. (2004). Immersion and Emotion: Their Impact on the Sense of Presence. CyberPsychology & Behavior, 7(6), 734-741. doi:10.1089/cpb.2004.7.734Hoffman, H. G., Patterson, D. R., Soltani, M., Teeley, A., Miller, W., & Sharar, S. R. (2009). Virtual Reality Pain Control during Physical Therapy Range of Motion Exercises for a Patient with Multiple Blunt Force Trauma Injuries. CyberPsychology & Behavior, 12(1), 47-49. doi:10.1089/cpb.2008.0056Baños, R. M., Botella, C., Guillen, V., García-Palacios, A., Quero, S., Bretón-López, J., & Alcañiz, M. (2009). An adaptive display to treat stress-related disorders: EMMA’s World. British Journal of Guidance & Counselling, 37(3), 347-356. doi:10.1080/03069880902957064Baños, R. M., Botella, C., Rubió, I., Quero, S., García-Palacios, A., & Alcañiz, M. (2008). Presence and Emotions in Virtual Environments: The Influence of Stereoscopy. CyberPsychology & Behavior, 11(1), 1-8. doi:10.1089/cpb.2007.9936Baños, R. M., Guillen, V., Quero, S., García-Palacios, A., Alcaniz, M., & Botella, C. (2011). A virtual reality system for the treatment of stress-related disorders: A preliminary analysis of efficacy compared to a standard cognitive behavioral program. International Journal of Human-Computer Studies, 69(9), 602-613. doi:10.1016/j.ijhcs.2011.06.002Bermudez i Badia, S., Quintero, L. V., Cameirao, M. S., Chirico, A., Triberti, S., Cipresso, P., & Gaggioli, A. (2019). Toward Emotionally Adaptive Virtual Reality for Mental Health Applications. IEEE Journal of Biomedical and Health Informatics, 23(5), 1877-1887. doi:10.1109/jbhi.2018.2878846Borkovec, T. D., & Costello, E. (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61(4), 611-619. doi:10.1037/0022-006x.61.4.611Bosse, T., Gerritsen, C., de Man, J., & Treur, J. (2014). Towards virtual training of emotion regulation. Brain Informatics, 1(1-4), 27-37. doi:10.1007/s40708-014-0004-9Brewer, W. F. (1996). What is recollective memory? Remembering our Past, 19-66. doi:10.1017/cbo9780511527913.002Cohn, M. A., Fredrickson, B. L., Brown, S. L., Mikels, J. A., & Conway, A. M. (2009). Happiness unpacked: Positive emotions increase life satisfaction by building resilience. Emotion, 9(3), 361-368. doi:10.1037/a0015952Fairbanks, R. J., & Wears, R. L. (2008). Hazards With Medical Devices: The Role of Design. Annals of Emergency Medicine, 52(5), 519-521. doi:10.1016/j.annemergmed.2008.07.008Felix, M. M. dos S., Ferreira, M. B. G., da Cruz, L. F., & Barbosa, M. H. (2019). Relaxation Therapy with Guided Imagery for Postoperative Pain Management: An Integrative Review. Pain Management Nursing, 20(1), 3-9. doi:10.1016/j.pmn.2017.10.014Felnhofer, A., Kothgassner, O. D., Schmidt, M., Heinzle, A.-K., Beutl, L., Hlavacs, H., & Kryspin-Exner, I. (2015). Is virtual reality emotionally arousing? Investigating five emotion inducing virtual park scenarios. International Journal of Human-Computer Studies, 82, 48-56. doi:10.1016/j.ijhcs.2015.05.004Ferrer-García, M., & Gutiérrez-Maldonado, J. (2012). The use of virtual reality in the study, assessment, and treatment of body image in eating disorders and nonclinical samples: A review of the literature. Body Image, 9(1), 1-11. doi:10.1016/j.bodyim.2011.10.001Ferrer-Garcia, M., Gutiérrez-Maldonado, J., & Riva, G. (2013). Virtual Reality Based Treatments in Eating Disorders and Obesity: A Review. Journal of Contemporary Psychotherapy, 43(4), 207-221. doi:10.1007/s10879-013-9240-1Fisher, J. D. (1974). Situation-specific variables as determinants of perceived environmental aesthetic quality and perceived crowdedness. Journal of Research in Personality, 8(2), 177-188. doi:10.1016/0092-6566(74)90019-1Folkman, S., & Moskowitz, J. T. (2000). Positive affect and the other side of coping. American Psychologist, 55(6), 647-654. doi:10.1037/0003-066x.55.6.647Fredrickson, B. L. (2001). The role of positive emotions in positive psychology: The broaden-and-build theory of positive emotions. American Psychologist, 56(3), 218-226. doi:10.1037/0003-066x.56.3.218Gilardi, S., Guglielmetti, C., & Pravettoni, G. (2013). Interprofessional team dynamics and information flow management in emergency departments. Journal of Advanced Nursing, 70(6), 1299-1309. doi:10.1111/jan.12284Gonçalves, R., Pedrozo, A. L., Coutinho, E. S. F., Figueira, I., & Ventura, P. (2012). Efficacy of Virtual Reality Exposure Therapy in the Treatment of PTSD: A Systematic Review. PLoS ONE, 7(12), e48469. doi:10.1371/journal.pone.0048469Gross, J. J. (1998). The Emerging Field of Emotion Regulation: An Integrative Review. Review of General Psychology, 2(3), 271-299. doi:10.1037/1089-2680.2.3.271Hemenover, S. H., & Bowman, N. D. (2018). Video games, emotion, and emotion regulation: expanding the scope. Annals of the International Communication Association, 42(2), 125-143. doi:10.1080/23808985.2018.1442239Hoffman, H. G., Chambers, G. T., Meyer, W. J., Arceneaux, L. L., Russell, W. J., Seibel, E. J., … Patterson, D. R. (2011). Virtual Reality as an Adjunctive Non-pharmacologic Analgesic for Acute Burn Pain During Medical Procedures. Annals of Behavioral Medicine, 41(2), 183-191. doi:10.1007/s12160-010-9248-7Holland, A. C., & Kensinger, E. A. (2010). Emotion and autobiographical memory. Physics of Life Reviews, 7(1), 88-131. doi:10.1016/j.plrev.2010.01.006Ip, H. H. S., Wong, S. W. L., Chan, D. F. Y., Byrne, J., Li, C., Yuan, V. S. N., … Wong, J. Y. W. (2018). Enhance emotional and social adaptation skills for children with autism spectrum disorder: A virtual reality enabled approach. Computers & Education, 117, 1-15. doi:10.1016/j.compedu.2017.09.010Korpela, K. M., Ylén, M., Tyrväinen, L., & Silvennoinen, H. (2008). Determinants of restorative experiences in everyday favorite places. Health & Place, 14(4), 636-652. doi:10.1016/j.healthplace.2007.10.008Korpela, K. M., & Ylén, M. P. (2009). Effectiveness of Favorite-Place Prescriptions. American Journal of Preventive Medicine, 36(5), 435-438. doi:10.1016/j.amepre.2009.01.022Kyle, G., Graefe, A., Manning, R., & Bacon, J. (2004). Effects of place attachment on users’ perceptions of social and environmental conditions in a natural setting. Journal of Environmental Psychology, 24(2), 213-225. doi:10.1016/j.jenvp.2003.12.006Lang, P. J. (s. f.). Fear reduction and fear behavior: Problems in treating a construct. Research in psychotherapy., 90-102. doi:10.1037/10546-004León-Pizarro, C., Gich, I., Barthe, E., Rovirosa, A., Farrús, B., Casas, F., … Arcusa, A. (2007). A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psycho-Oncology, 16(11), 971-979. doi:10.1002/pon.1171Lobel, A., Granic, I., & Engels, R. C. M. E. (2014). Stressful Gaming, Interoceptive Awareness, and Emotion Regulation Tendencies: A Novel Approach. Cyberpsychology, Behavior, and Social Networking, 17(4), 222-227. doi:10.1089/cyber.2013.0296Maples-Keller, J. L., Bunnell, B. E., Kim, S.-J., & Rothbaum, B. O. (2017). The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders. Harvard Review of Psychiatry, 25(3), 103-113. doi:10.1097/hrp.0000000000000138Maples-Keller, J. L., Yasinski, C., Manjin, N., & Rothbaum, B. O. (2017). Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress. Neurotherapeutics, 14(3), 554-563. doi:10.1007/s13311-017-0534-yMarín-Morales, J., Higuera-Trujillo, J. L., Greco, A., Guixeres, J., Llinares, C., Scilingo, E. P., … Valenza, G. (2018). Affective computing in virtual reality: emotion recognition from brain and heartbeat dynamics using wearable sensors. Scientific Reports, 8(1). doi:10.1038/s41598-018-32063-4Marks, I. M., & Gelder, M. G. (1965). A Controlled Retrospective Study of Behaviour Therapy in Phobic Patients. British Journal of Psychiatry, 111(476), 561-573. doi:10.1192/bjp.111.476.561Miller, K. M. (1987). Deep Breathing Relaxation. AORN Journal, 45(2), 484-488. doi:10.1016/s0001-2092(07)68361-6Mitroff, S. R., Biggs, A. T., Adamo, S. H., Dowd, E. W., Winkle, J., & Clark, K. (2015). What can 1 billion trials tell us about visual search? Journal of Experimental Psychology: Human Perception and Performance, 41(1), 1-5. doi:10.1037/xhp0000012Mühlberger, A., Herrmann, M. J., Wiedemann, G., Ellgring, H., & Pauli, P. (2001). Repeated exposure of flight phobics to flights in virtual reality. Behaviour Research and Therapy, 39(9), 1033-1050. doi:10.1016/s0005-7967(00)00076-0Oliver, M. B., Bowman, N. D., Woolley, J. K., Rogers, R., Sherrick, B. I., & Chung, M.-Y. (2016). Video games as meaningful entertainment experiences. Psychology of Popular Media Culture, 5(4), 390-405. doi:10.1037/ppm0000066Oliver, M. B., Hartmann, T., & Woolley, J. K. (2012). Elevation in Response to Entertainment Portrayals of Moral Virtue. Human Communication Research, 38(3), 360-378. doi:10.1111/j.1468-2958.2012.01427.xParsons, T. D., & Reinebold, J. L. (2012). Adaptive virtual environments for neuropsychological assessment in serious games. IEEE Transactions on Consumer Electronics, 58(2), 197-204. doi:10.1109/tce.2012.6227413Parsons, T. D., & Rizzo, A. A. (2008). Affective outcomes of virtual reality exposure therapy for anxiety and specific phobias: A meta-analysis. Journal of Behavior Therapy and Experimental Psychiatry, 39(3), 250-261. doi:10.1016/j.jbtep.2007.07.007Parsons, T. D., Rizzo, A. A., Rogers, S., & York, P. (2009). Virtual reality in paediatric rehabilitation: A review. Developmental Neurorehabilitation, 12(4), 224-238. doi:10.1080/17518420902991719Picard, R. W., Vyzas, E., & Healey, J. (2001). Toward machine emotional intelligence: analysis of affective physiological state. IEEE Transactions on Pattern Analysis and Machine Intelligence, 23(10), 1175-1191. doi:10.1109/34.954607Pressman, S. D., & Cohen, S. (2005). Does positive affect influence health? Psychological Bulletin, 131(6), 925-971. doi:10.1037/0033-2909.131.6.925Renzi, C., Riva, S., Masiero, M., & Pravettoni, G. (2016). The choice dilemma in chronic hematological conditions: Why choosing is not only a medical issue? A psycho-cognitive perspective. Critical Reviews in Oncology/Hematology, 99, 134-140. doi:10.1016/j.critrevonc.2015.12.010Riva, G., Mantovani, F., Capideville, C. S., Preziosa, A., Morganti, F., Villani, D., … Alcañiz, M. (2007). Affective Interactions Using Virtual Reality: The Link between Presence and Emotions. CyberPsychology & Behavior, 10(1), 45-56. doi:10.1089/cpb.2006.9993Rizzo, A., Parsons, T. D., Lange, B., Kenny, P., Buckwalter, J. G., Rothbaum, B., … Reger, G. (2011). Virtual Reality Goes to War: A Brief Review of the Future of Military Behavioral Healthcare. Journal of Clinical Psychology in Medical Settings, 18(2), 176-187. doi:10.1007/s10880-011-9247-2Rodríguez, A., Rey, B., Clemente, M., Wrzesien, M., & Alcañiz, M. (2015). Assessing brain activations associated with emotional regulation during virtual reality mood induction procedures. Expert Systems with Applications, 42(3), 1699-1709. doi:10.1016/j.eswa.2014.10.006Rodriguez, A., Rey, B., Vara, M. D., Wrzesien, M., Alcaniz, M., Banos, R. M., & Perez-Lopez, D. (2015). A VR-Based Serious Game for Studying Emotional Regulation in Adolescents. IEEE Computer Graphics and Applications, 35(1), 65-73. doi:10.1109/mcg.2015.8Rubin, D. C. (2005). A Basic-Systems Approach to Autobiographical Memory. Current Directions in Psychological Science, 14(2), 79-83. doi:10.1111/j.0963-7214.2005.00339.xRubin, D. C., & Kozin, M. (1984). Vivid memories. Cognition, 16(1), 81-95. doi:10.1016/0010-0277(84)90037-4Saadatmand, V., Rejeh, N., Heravi-Karimooi, M., Tadrisi, S. D., Zayeri, F., Vaismoradi, M., & Jasper, M. (2013). Effect of nature-based sounds’ intervention on agitation, anxiety, and stress in patients under mechanical ventilator support: A randomised controlled trial. International Journal of Nursing Studies, 50(7), 895-904. doi:10.1016/j.ijnurstu.2012.11.018Serino, S., Triberti, S., Villani, D., Cipresso, P., Gaggioli, A., & Riva, G. (2013). Toward a validation of cyber-interventions for stress disorders based on stress inoculation training: a systematic review. Virtual Reality, 18(1), 73-87. doi:10.1007/s10055-013-0237-6Triberti, S., & Barello, S. (2016). The quest for engaging AmI: Patient engagement and experience design tools to promote effective assisted living. Journal of Biomedical Informatics, 63, 150-156. doi:10.1016/j.jbi.2016.08.010Tugade, M. M., Fredrickson, B. L., & Feldman Barrett, L. (2004). Psychological Resilience and Positive Emotional Granularity: Examining the Benefits of Positive Emotions on Coping and Health. Journal of Personality, 72(6), 1161-1190. doi:10.1111/j.1467-6494.2004.00294.xTulving, E. (1985). Memory and consciousness. Canadian Psychology/Psychologie canadienne, 26(1), 1-12. doi:10.1037/h0080017Tusek, D. L., & Cwynar, R. E. (2000). Strategies for Implementing a Guided Imagery Program to Enhance Patient Experience. AACN Clinical Issues: Advanced Practice in Acute & Critical Care, 11(1), 68-76. doi:10.1097/00044067-200002000-00009Vara, M. D., Baños, R. M., Rasal, P., Rodríguez, A., Rey, B., Wrzesien, M., & Alcañiz, M. (2016). A game for emotional regulation in adolescents: The (body) interface device matters. Computers in Human Behavior, 57, 267-273. doi:10.1016/j.chb.2015.12.033Vempati, R. P., & Telles, S. (2002). Yoga-Based Guided Relaxation Reduces Sympathetic Activity Judged from Baseline Levels. Psychological Reports, 90(2), 487-494. doi:10.2466/pr0.2002.90.2.487Villani, D., Carissoli, C., Triberti, S., Marchetti, A., Gilli, G., & Riva, G. (2018). Videogames for Emotion Regulation: A Systematic Review. Games for Health Journal, 7(2), 85-99. doi:10.1089/g4h.2017.0108Villani, D., Riva, F., & Riva, G. (2007). New technologies for relaxation: The role of presence. International Journal of Stress Management, 14(3), 260-274. doi:10.1037/1072-5245.14.3.260Villani, D., Rotasperti, C., Cipresso, P., Triberti, S., Carissoli, C., & Riva, G. (2016). Assessing the Emotional State of Job Applicants Through a Virtual Reality Simulation: A Psycho-Physiological Study. eHealth 360°, 119-126. doi:10.1007/978-3-319-49655-9_16Witvliet, C. van O., Ludwig, T. E., & Laan, K. L. V. (2001). Granting Forgiveness or Harboring Grudges: Implications for Emotion, Physiology, and Health. Psychological Science, 12(2), 117-123. doi:10.1111/1467-9280.00320Wright, D., & Gaskell, G. (1992). The Construction and Function of Vivid Memories. Theoretical Perspectives on Autobiographical Memory, 275-292. doi:10.1007/978-94-015-7967-4_16Wrzesien, M., Rodríguez, A., Rey, B., Alcañiz, M., Baños, R. M., & Vara, M. D. (2015). How the physical similarity of avatars can influence the learning of emotion regulation strategies in teenagers. Computers in Human Behavior, 43, 101-111. doi:10.1016/j.chb.2014.09.02

International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.

The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, but robust common variants have yet to be identified. In a multi-ethnic cohort including over 30,000 PTSD cases and 170,000 controls we conduct a genome-wide association study of PTSD. We demonstrate SNP-based heritability estimates of 5-20%, varying by sex. Three genome-wide significant loci are identified, 2 in European and 1 in African-ancestry analyses. Analyses stratified by sex implicate 3 additional loci in men. Along with other novel genes and non-coding RNAs, a Parkinson's disease gene involved in dopamine regulation, PARK2, is associated with PTSD. Finally, we demonstrate that polygenic risk for PTSD is significantly predictive of re-experiencing symptoms in the Million Veteran Program dataset, although specific loci did not replicate. These results demonstrate the role of genetic variation in the biology of risk for PTSD and highlight the necessity of conducting sex-stratified analyses and expanding GWAS beyond European ancestry populations

Enhancing discovery of genetic variants for posttraumatic stress disorder through integration of quantitative phenotypes and trauma exposure information

Background Posttraumatic stress disorder (PTSD) is heritable and a potential consequence of exposure to traumatic stress. Evidence suggests that a quantitative approach to PTSD phenotype measurement and incorporation of lifetime trauma exposure (LTE) information could enhance the discovery power of PTSD genome-wide association studies (GWASs). Methods A GWAS on PTSD symptoms was performed in 51 cohorts followed by a fixed-effects meta-analysis (N = 182,199 European ancestry participants). A GWAS of LTE burden was performed in the UK Biobank cohort (N = 132,988). Genetic correlations were evaluated with linkage disequilibrium score regression. Multivariate analysis was performed using Multi-Trait Analysis of GWAS. Functional mapping and annotation of leading loci was performed with FUMA. Replication was evaluated using the Million Veteran Program GWAS of PTSD total symptoms. Results GWASs of PTSD symptoms and LTE burden identified 5 and 6 independent genome-wide significant loci, respectively. There was a 72% genetic correlation between PTSD and LTE. PTSD and LTE showed largely similar patterns of genetic correlation with other traits, albeit with some distinctions. Adjusting PTSD for LTE reduced PTSD heritability by 31%. Multivariate analysis of PTSD and LTE increased the effective sample size of the PTSD GWAS by 20% and identified 4 additional loci. Four of these 9 PTSD loci were independently replicated in the Million Veteran Program. Conclusions Through using a quantitative trait measure of PTSD, we identified novel risk loci not previously identified using prior case-control analyses. PTSD and LTE have a high genetic overlap that can be leveraged to increase discovery power through multivariate methods

International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci

The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, but robust common variants have yet to be identified. In a multi-ethnic cohort including over 30,000 PTSD cases and 170,000 controls we conduct a genome-wide association study of PTSD. We demonstrate SNP-based heritability estimates of 5–20%, varying by sex. Three genome-wide significant loci are identified, 2 in European and 1 in African-ancestry analyses. Analyses stratified by sex implicate 3 additional loci in men. Along with other novel genes and non-coding RNAs, a Parkinson’s disease gene involved in dopamine regulation, PARK2, is associated with PTSD. Finally, we demonstrate that polygenic risk for PTSD is significantly predictive of re-experiencing symptoms in the Million Veteran Program dataset, although specific loci did not replicate. These results demonstrate the role of genetic variation in the biology of risk for PTSD and highlight the necessity of conducting sex-stratified analyses and expanding GWAS beyond European ancestry populations. © 2019, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply

Enhancing Discovery of Genetic Variants for Posttraumatic Stress Disorder Through Integration of Quantitative Phenotypes and Trauma Exposure Information

Funding Information: This work was supported by the National Institute of Mental Health / U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium ), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience . Statistical analyses were carried out on the LISA/Genetic Cluster Computer ( https://userinfo.surfsara.nl/systems/lisa ) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. Funding Information: MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc., RallyPoint Networks, Inc., Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the National Institute of Mental Health/ U.S. Army Medical Research and Development Command (Grant No. R01MH106595 [to CMN, IL, MBS, KJRe, and KCK], National Institutes of Health (Grant No. 5U01MH109539 to the Psychiatric Genomics Consortium), and Brain & Behavior Research Foundation (Young Investigator Grant [to KWC]). Genotyping of samples was provided in part through the Stanley Center for Psychiatric Genetics at the Broad Institute supported by Cohen Veterans Bioscience. Statistical analyses were carried out on the LISA/Genetic Cluster Computer (https://userinfo.surfsara.nl/systems/lisa) hosted by SURFsara. This research has been conducted using the UK Biobank resource (Application No. 41209). This work would have not been possible without the financial support provided by Cohen Veterans Bioscience, the Stanley Center for Psychiatric Genetics at the Broad Institute, and One Mind. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the U.S. Department of the Army or the Department of Defense. We thank the investigators who comprise the PGC-PTSD working group and especially the more than 206,000 research participants worldwide who shared their life experiences and biological samples with PGC-PTSD investigators. We thank Mark Zervas for his critical input. Full acknowledgments are in Supplement 1. MBS has in the past 3 years received consulting income from Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech and has stock options in Oxeia Biopharmaceuticals and Epivario. In the past 3 years, NPD has held a part-time paid position at Cohen Veterans Bioscience, has been a consultant for Sunovion Pharmaceuticals, and is on the scientific advisory board for Sentio Solutions for unrelated work. In the past 3 years, KJRe has been a consultant for Datastat, Inc. RallyPoint Networks, Inc. Sage Pharmaceuticals, and Takeda. JLM-K has received funding and a speaking fee from COMPASS Pathways. MU has been a consultant for System Analytic. HRK is a member of the Dicerna scientific advisory board and a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which during the past 3 years was supported by Alkermes, Amygdala Neurosciences, Arbor Pharmaceuticals, Dicerna, Ethypharm, Indivior, Lundbeck, Mitsubishi, and Otsuka. HRK and JG are named as inventors on Patent Cooperative Treaty patent application number 15/878,640, entitled ?Genotype-guided dosing of opioid agonists,? filed January 24, 2018. RP and JG are paid for their editorial work on the journal Complex Psychiatry. OAA is a consultant to HealthLytix. All other authors report no biomedical financial interests or potential conflicts of interest. Publisher Copyright: © 2021 Society of Biological PsychiatryBackground: Posttraumatic stress disorder (PTSD) is heritable and a potential consequence of exposure to traumatic stress. Evidence suggests that a quantitative approach to PTSD phenotype measurement and incorporation of lifetime trauma exposure (LTE) information could enhance the discovery power of PTSD genome-wide association studies (GWASs). Methods: A GWAS on PTSD symptoms was performed in 51 cohorts followed by a fixed-effects meta-analysis (N = 182,199 European ancestry participants). A GWAS of LTE burden was performed in the UK Biobank cohort (N = 132,988). Genetic correlations were evaluated with linkage disequilibrium score regression. Multivariate analysis was performed using Multi-Trait Analysis of GWAS. Functional mapping and annotation of leading loci was performed with FUMA. Replication was evaluated using the Million Veteran Program GWAS of PTSD total symptoms. Results: GWASs of PTSD symptoms and LTE burden identified 5 and 6 independent genome-wide significant loci, respectively. There was a 72% genetic correlation between PTSD and LTE. PTSD and LTE showed largely similar patterns of genetic correlation with other traits, albeit with some distinctions. Adjusting PTSD for LTE reduced PTSD heritability by 31%. Multivariate analysis of PTSD and LTE increased the effective sample size of the PTSD GWAS by 20% and identified 4 additional loci. Four of these 9 PTSD loci were independently replicated in the Million Veteran Program. Conclusions: Through using a quantitative trait measure of PTSD, we identified novel risk loci not previously identified using prior case-control analyses. PTSD and LTE have a high genetic overlap that can be leveraged to increase discovery power through multivariate methods.publishersversionpublishe

International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci

The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, but robust common variants have yet to be identified. In a multi-ethnic cohort including over 30,000 PTSD cases and 170,000 controls we conduct a genome-wide association study of PTSD. We demonstrate SNP-based heritability estimates of 5–20%, varying by sex. Three genome-wide significant loci are identified, 2 in European and 1 in African-ancestry analyses. Analyses stratified by sex implicate 3 additional loci in men. Along with other novel genes and non-coding RNAs, a Parkinson’s disease gene involved in dopamine regulation, PARK2, is associated with PTSD. Finally, we demonstrate that polygenic risk for PTSD is significantly predictive of re-experiencing symptoms in the Million Veteran Program dataset, although specific loci did not replicate. These results demonstrate the role of genetic variation in the biology of risk for PTSD and highlight the necessity of conducting sex-stratified analyses and expanding GWAS beyond European ancestry populations